Publications Authored by Barbara Schmalfeldt

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.

Mol Carcinog 2019 Dec 23;58(12):2306-2315. Epub 2019 Sep 23.

Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Download full-text PDF	Source
http://dx.doi.org/10.1002/mc.23119	DOI Listing

December 2019

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Authors:

Fabienne Hamester Karen Legler Beatrice Wichert Nicole Kelle Kathrin Eylmann Maila Rossberg Yi Ding Sascha Kürti Barbara Schmalfeldt Karin Milde-Langosch Leticia Oliveira-Ferrer

Br J Cancer 2019 Nov 29;121(11):944-953. Epub 2019 Oct 29.

Department of Gynecology, University Medical Centre Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41416-019-0607-2	DOI Listing

November 2019

Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients.

Authors:

Malgorzata Banys-Paluchowski Karin Milde-Langosch Tanja Fehm Isabell Witzel Leticia Oliveira-Ferrer Barbara Schmalfeldt Volkmar Müller

Breast Cancer Res Treat 2019 Oct 23. Epub 2019 Oct 23.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-019-05474-8	DOI Listing

October 2019

Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.

Gynecol Oncol 2019 09 18;154(3):565-570. Epub 2019 Jun 18.

Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2019.06.013	DOI Listing

September 2019

Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.

Clin Cancer Res 2019 Sep 16. Epub 2019 Sep 16.

Department of Gynecology and Gynecologic Oncology, Kliniken-Essen-Mitte, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1741	DOI Listing

September 2019

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.

Aging (Albany NY) 2019 Sep 18;11(18):7796-7804. Epub 2019 Sep 18.

Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/aging.102287	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781992	PMC

September 2019

Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.

Authors:

Donata Grimm Katharina Prieske Sabrina Mathey Sascha Kuerti Eike Burandt Barbara Schmalfeldt Linn Woelber

Int J Gynecol Cancer 2019 03 4;29(3):466-473. Epub 2019 Jan 4.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1136/ijgc-2018-000046	DOI Listing

March 2019

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.

N Engl J Med 2019 02;380(9):822-832

From the Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen (P. Harter, A. du Bois), Department of Gynecology, Charité-Universitätsmedizin Berlin, Berlin (J.S.), the Coordinating Center for Clinical Trials, Philipps University Marburg (A.R., C.S.-B.), and the Department of Gynecology and Obstetrics, University Hospital Giessen and Marburg (U.W.), Marburg, the Department of Gynecology and Obstetrics, Kaiserswerther Diakonie (B.L.), and the Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf (W.M.), Düsseldorf, the Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald (A.M.), the Department of Gynecology, University Medical Center Hamburg-Eppendorf (S.M.), and the Department of Gynecology and Obstetrics, Albertinen Krankenhaus (I.L.), Hamburg, University Women's Hospital, Department of Gynecology and Reproductive Medicine and Center for Gynecologic Oncology, Jena University Hospital, Jena (I.B.R.), the Department of Obstetrics and Gynecology, University Munich rechts der Isar (B.S.), and the Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-Universität München (A. Burges), Munich, West German Cancer Center, Department of Gynecology and Obstetrics, University of Duisburg-Essen, Duisburg (R.K.), the Department of Gynecology and Obstetrics, University Hospital Kiel, Kiel (F.H.), University Medical Center Freiburg, Freiburg (A.H.), University Medical Center Mainz, Department of Gynecology and Obstetrics, Mainz (A.H.), and the Department of Gynecology and Obstetrics, Hannover Medical School, Hannover (P. Hillemanns) - all in Germany; the Gynecologic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (D.L., F.R.), and the Department of Gynecologic Oncology, European Institute of Oncology, University of Milan (G.A.), Milan, the Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome (G.S.), Gynecologic Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli, IRCCS Fondazione G. Pascale, Naples (S.G.), and the Cancer Reference Center, Centro di Riferimento Oncologico, Aviano (G.G.) - all in Italy; the Department of Gynecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium (I.V.); the Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria (C.M.); the Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea (J.-W.K.); and the Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic (D.C.).

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1056/NEJMoa1808424	DOI Listing

February 2019

What is the evidence for lymphadenectomy in presumed early ovarian cancer?

Arch Gynecol Obstet 2019 01;299(1):1-5

Department of Gynecology, Charité Medical University of Berlin, Berlin, Germany.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s00404-018-4945-8	Publisher Site
http://dx.doi.org/10.1007/s00404-018-4945-8	DOI Listing

January 2019

A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.

Authors:

Daniela Loessner Anja Rockstroh Ali Shokoohmand Boris M Holzapfel Ferdinand Wagner Jeremy Baldwin Melanie Boxberg Barbara Schmalfeldt Ernst Lengyel Judith A Clements Dietmar W Hutmacher

Biomaterials 2019 01 16;190-191:63-75. Epub 2018 Oct 16.

Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, Brisbane, QLD 4059, Australia; Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, Brisbane, QLD 4102, Australia; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Drive, Atlanta, GA 30332-0405, USA; Institute for Advanced Study, Technical University Munich, Lichtenbergstr. 2a, 85748 Garching, Germany. Electronic address:

View Article

Download full-text PDF	Source
https://linkinghub.elsevier.com/retrieve/pii/S01429612183072	Publisher Site
http://dx.doi.org/10.1016/j.biomaterials.2018.10.014	DOI Listing

January 2019

Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions.

Authors:

Donata Grimm Linn Woelber Katharina Prieske Barbara Schmalfeldt Sascha Kürti Chia-Jung Busch Ingo Teudt Oliver Brummer Volkmar Mueller Thomas Meyer

Eur J Microbiol Immunol (Bp) 2018 Dec 12;8(4):107-111. Epub 2018 Dec 12.

Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Germany.

View Article

Download full-text PDF	Source
https://www.akademiai.com/doi/10.1556/1886.2018.00018	Publisher Site
http://dx.doi.org/10.1556/1886.2018.00018	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348707	PMC

December 2018

Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.

Authors:

Beatrice Wichert Karin Milde-Langosch Vladimir Galatenko Barbara Schmalfeldt Leticia Oliveira-Ferrer

Glycobiology 2018 11;28(11):898-903

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1093/glycob/cwy065	DOI Listing

November 2018

Clinical relevance of cytoskeleton associated proteins for ovarian cancer.

Authors:

Johanna Schiewek Udo Schumacher Tobias Lange Simon A Joosse Harriet Wikman Klaus Pantel Marina Mikhaylova Matthias Kneussel Stefan Linder Barbara Schmalfeldt Leticia Oliveira-Ferrer Sabine Windhorst

J Cancer Res Clin Oncol 2018 Nov 9;144(11):2195-2205. Epub 2018 Aug 9.

Department of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1007/s00432-018-2710-9	Publisher Site
http://dx.doi.org/10.1007/s00432-018-2710-9	DOI Listing

November 2018

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.

Authors:

Leticia Oliveira-Ferrer Roshni Goswami Vladimir Galatenko Yi Ding Kathrin Eylmann Karen Legler Sascha Kürti Barbara Schmalfeldt Karin Milde-Langosch

Dis Markers 2018 28;2018:6714287. Epub 2018 Jun 28.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1155/2018/6714287	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046165	PMC

October 2018

Participation of elderly gynecological cancer patients in clinical trials.

Authors:

Katharina Prieske Fabian Trillsch Gülten Oskay-Özcelik Radoslav Chekerov Christiane Bleich Leticia Oliveira-Ferrer Donata Grimm Sascha Kuerti Volkmar Mueller Anna Suling Barbara Schmalfeldt Jalid Sehouli Sven Mahner Linn Woelber

Arch Gynecol Obstet 2018 10 30;298(4):797-804. Epub 2018 Aug 30.

Department of Gynecology and Gynecologic Oncology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00404-018-4886-2	DOI Listing

October 2018

Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer.

Authors:

Linn Woelber Simon A Joosse Donata Grimm Sabrina Mathey Sven Mahner Eike Burandt Susanne Klutmann Barbara Schmalfeldt Katharina Prieske

Int J Gynecol Cancer 2018 09;28(7):1403-1409

Departments of Gynecology and Gynecologic Oncology, and.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/IGC.0000000000001298	DOI Listing

September 2018

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer.

Authors:

Karen Legler Ricarda Rosprim Tosca Karius Kathrin Eylmann Maila Rossberg Ralph M Wirtz Volkmar Müller Isabell Witzel Barbara Schmalfeldt Karin Milde-Langosch Leticia Oliveira-Ferrer

Br J Cancer 2018 03 30;118(6):847-856. Epub 2018 Jan 30.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/bjc.2017.472	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877434	PMC

March 2018

[Current Status of Targeted Treatment in Breast Cancer].

Authors:

Katharina Seiffert Barbara Schmalfeldt Volkmar Müller

Dtsch Med Wochenschr 2017 Nov 27;142(22):1669-1675. Epub 2017 Oct 27.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1055/s-0043-108468	DOI Listing

November 2017

Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients.

Authors:

Stefanie Avril Yasemin Dincer Katharina Malinowsky Claudia Wolff Sibylle Gündisch Alexander Hapfelmeier Melanie Boxberg Holger Bronger Karl-Friedrich Becker Barbara Schmalfeldt

Oncotarget 2017 Nov 8;8(58):97851-97861. Epub 2017 Jun 8.

Department of Obstetrics and Gynecology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/oncotarget.18415	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716696	PMC

November 2017

Loss of promotor hypermethylation in recurrent high-grade ovarian cancer.

Authors:

Katharina Prieske Stefan Prieske Simon A Joosse Fabian Trillsch Donata Grimm Eike Burandt Sven Mahner Barbara Schmalfeldt Karin Milde-Langosch Leticia Oliveira-Ferrer Linn Woelber

Oncotarget 2017 Oct 15;8(47):83063-83074. Epub 2017 Sep 15.

Department of Gynecology and Gynecologic Oncology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/oncotarget.20945	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669950	PMC

October 2017

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.

Br J Cancer 2017 Sep 17;117(7):1063-1069. Epub 2017 Aug 17.

Deparment of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/bjc.2017.267	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625672	PMC

September 2017

Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia.

Authors:

Linn Woelber Julia Breuer Thomas Meyer Eik Vettorazzi Katharina Prieske Inga Bohlmann Chia-Jung Busch Ingo Teudt Oliver Brummer Volkmar Mueller Barbara Schmalfeldt Donata Grimm

J Low Genit Tract Dis 2017 Jul;21(3):177-183

1Department of Gynaecology and Gynaecologic Oncology, University Medical Center Hamburg-Eppendorf, Germany; 2Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Germany; 3Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, University Medical Centre Hamburg-Eppendorf, Germany; 5Department of Otolaryngology, Head and Neck Surgery, Asklepios Klinik Hamburg Altona, Germany; 6HNO-in-Altona, Private Otorhinolaryngology Praxis, Hamburg, Germany; 7Tagesklinik Altonaer Strasse, Private Gynaecology Praxis, Hamburg, Germany; and 8Department of Gynaecology and Gynaecologic Oncology, Medical Center Asklepios Altona, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/LGT.0000000000000313	DOI Listing

July 2017

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience.

Authors:

Svenja Jendrian Katharina Steffens Barbara Schmalfeldt Elena Laakmann Corinna Bergelt Isabell Witzel

Breast Cancer Res Treat 2017 Jun 21;163(3):517-526. Epub 2017 Mar 21.

Department of Gynecology, University Medical Center, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-017-4208-6	DOI Listing

June 2017

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.

Authors:

Sascha Kuerti Leticia Oliveira-Ferrer Karin Milde-Langosch Barbara Schmalfeldt Karen Legler Linn Woelber Katharina Prieske Sven Mahner Fabian Trillsch

Oncotarget 2017 Jun;8(26):43218-43227

Department of Obstetrics and Gynaecology, University of Munich, Munich 81377, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/oncotarget.17978	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522140	PMC

June 2017

Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.

Ann Surg Oncol 2017 May 28;24(5):1314-1321. Epub 2016 Nov 28.

Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1245/s10434-016-5687-0	DOI Listing

May 2017

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.

Cancer Causes Control 2017 May 14;28(5):469-486. Epub 2017 Mar 14.

Deparment of Cancer Prevention and Control, Roswell Park Cancer Institute, A-352 Carlton House, Elm and Carlton Streets, Buffalo, NY, 14263, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10552-017-0867-1	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500209	PMC

May 2017

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.

Authors:

Isabell Witzel Anna K Marx Volkmar Müller Harriet Wikman Jakob Matschke Udo Schumacher Christine Stürken Peter Prehm Elena Laakmann Barbara Schmalfeldt Karin Milde-Langosch Leticia Oliveira-Ferrer

Breast Cancer Res Treat 2017 04 6;162(3):427-438. Epub 2017 Feb 6.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10549-017-4135-6	DOI Listing

April 2017

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Authors:

Lara E Sucheston-Campbell Rikki Cannioto Alyssa I Clay John Lewis Etter Kevin H Eng Song Liu Sebastiano Battaglia Qiang Hu J Brian Szender Albina Minlikeeva Janine M Joseph Paul Mayor Scott I Abrams Brahm H Segal Paul K Wallace Kah Teong Soh Emese Zsiros Hoda Anton-Culver Elisa V Bandera Matthias W Beckmann Andrew Berchuck Line Bjorge Amanda Bruegl Ian G Campbell Shawn Patrice Campbell Georgia Chenevix-Trench Daniel W Cramer Agnieszka Dansonka-Mieszkowska Fanny Dao Brenda Diergaarde Thilo Doerk Jennifer A Doherty Andreas du Bois Diana Eccles Svend Aage Engelholm Peter A Fasching Simon A Gayther Aleksandra Gentry-Maharaj Rosalind M Glasspool Marc T Goodman Jacek Gronwald Philipp Harter Alexander Hein Florian Heitz Peter Hillemmanns Claus Høgdall Estrid V S Høgdall Tomasz Huzarski Allan Jensen Sharon E Johnatty Audrey Jung Beth Y Karlan Reudiger Klapdor Tomasz Kluz Bożena Konopka Susanne Krüger Kjær Jolanta Kupryjanczyk Diether Lambrechts Jenny Lester Jan Lubiński Douglas A Levine Lene Lundvall Valerie McGuire Iain A McNeish Usha Menon Francesmary Modugno Roberta B Ness Sandra Orsulic James Paul Celeste Leigh Pearce Tanja Pejovic Paul Pharoah Susan J Ramus Joseph Rothstein Mary Anne Rossing Matthias Rübner Joellen M Schildkraut Barbara Schmalfeldt Ira Schwaab Nadeem Siddiqui Weiva Sieh Piotr Sobiczewski Honglin Song Kathryn L Terry Els Van Nieuwenhuysen Adriaan Vanderstichele Ignace Vergote Christine S Walsh Penelope M Webb Nicolas Wentzensen Alice S Whittemore Anna H Wu Argyrios Ziogas Kunle Odunsi Jenny Chang-Claude Ellen L Goode Kirsten B Moysich

Cancer Epidemiol Biomarkers Prev 2017 03 27;26(3):420-424. Epub 2016 Sep 27.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF	Source
http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EP	Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-16-0631	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500198	PMC

March 2017

Sarcopenia in Advanced Serous Ovarian Cancer.

Authors:

Holger Bronger Philipp Hederich Alexander Hapfelmeier Stephan Metz Peter B Noël Marion Kiechle Barbara Schmalfeldt

Int J Gynecol Cancer 2017 02;27(2):223-232

*Department of Gynecology and Obstetrics, Klinikum rechts der Isar, †Institute of Medical Statistics and Epidemiology, and ‡Department of Diagnostic and Interventional Radiology, Technische Universität München, Munich; and §Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/IGC.0000000000000867	DOI Listing

February 2017

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.

Oncotarget 2016 Dec;7(49):81322-81331

Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.18632/oncotarget.13227	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348395	PMC

December 2016

Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.

Eur J Cancer 2016 12 10;69:180-188. Epub 2016 Nov 10.

Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany; Department of Gynecology, University of Munich (LMU), Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2016.09.038	DOI Listing

December 2016

Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].

Authors:

Carlota Claussen Alma-Verena Rausch Susanne Lezius Ali Amirkhosravi Monica Davila John L Francis Yohei M Hisada Nigel Mackman Carsten Bokemeyer Barbara Schmalfeldt Sven Mahner Florian Langer

Thromb Res 2016 10 16;146:135. Epub 2016 Sep 16.

II. Medizinische Klinik und Poliklinik, Onkologisches Zentrum, Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Martinistr 52, D-20246 Hamburg, Germany. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.thromres.2016.09.008	DOI Listing

October 2016

Patterns of distant metastases in vulvar cancer.

Authors:

Katharina Prieske Nicole Haeringer Donata Grimm Fabian Trillsch Christine Eulenburg Eike Burandt Barbara Schmalfeldt Sven Mahner Volkmar Mueller Linn Woelber

Gynecol Oncol 2016 09 9;142(3):427-34. Epub 2016 Jul 9.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.009	DOI Listing

September 2016

Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914].

Eur J Cancer 2016 Sep 25;65:192-193. Epub 2016 Jul 25.

Universitätsklinik und Poliklinik für Gynäkologie, Universitätsklinikum, Halle, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2016.06.014	DOI Listing

September 2016

The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node.

Authors:

Linn Woelber Christine Eulenburg Donata Grimm Fabian Trillsch Inga Bohlmann Eike Burandt Jan Dieckmann Susanne Klutmann Barbara Schmalfeldt Sven Mahner Katharina Prieske

Ann Surg Oncol 2016 08 8;23(8):2508-14. Epub 2016 Feb 8.

Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1245/s10434-016-5114-6	DOI Listing

August 2016

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer.

Authors:

Holger Bronger Judith Singer Claudia Windmüller Ute Reuning Daniela Zech Claire Delbridge Julia Dorn Marion Kiechle Barbara Schmalfeldt Manfred Schmitt Stefanie Avril

Br J Cancer 2016 08 4;115(5):553-63. Epub 2016 Aug 4.

Department of Pathology, Technical University of Munich, Ismaninger Straße 22, 81675 Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/bjc.2016.172	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997538	PMC

August 2016

Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.

Cancer Epidemiol Biomarkers Prev 2016 07 6;25(7):1114-24. Epub 2016 May 6.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1330	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930728	PMC

July 2016

Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.

Authors:

Rikki A Cannioto Michael J LaMonte Linda E Kelemen Harvey A Risch Kevin H Eng Albina N Minlikeeva Chi-Chen Hong J Brian Szender Lara Sucheston-Campbell Janine M Joseph Andrew Berchuck Jenny Chang-Claude Daniel W Cramer Anna DeFazio Brenda Diergaarde Thilo Dörk Jennifer A Doherty Robert P Edwards Brooke L Fridley Grace Friel Ellen L Goode Marc T Goodman Peter Hillemanns Estrid Hogdall Satoyo Hosono Joseph L Kelley Susanne K Kjaer Rüdiger Klapdor Keitaro Matsuo Kunle Odunsi Christina M Nagle Catherine M Olsen Lisa E Paddock Celeste L Pearce Malcolm C Pike Mary A Rossing Barbara Schmalfeldt Brahm H Segal Elizabeth A Szamreta Pamela J Thompson Chiu-Chen Tseng Robert Vierkant Joellen M Schildkraut Nicolas Wentzensen Kristine G Wicklund Stacey J Winham Anna H Wu Francesmary Modugno Roberta B Ness Allan Jensen Penelope M Webb Kathryn Terry Elisa V Bandera Kirsten B Moysich

Br J Cancer 2016 06 14;115(1):95-101. Epub 2016 Jun 14.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1038/bjc.2016.153	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931371	PMC

June 2016

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.

Authors:

Carlota Claussen Alma-Verena Rausch Susanne Lezius Ali Amirkhosravi Monica Davila John L Francis Yohei M Hisada Nigel Mackman Carsten Bokemeyer Barbara Schmalfeldt Sven Mahner Florian Langer

Thromb Res 2016 05 2;141:39-48. Epub 2016 Mar 2.

II. Medizinische Klinik und Poliklinik, Onkologisches Zentrum - Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.thromres.2016.03.002	DOI Listing

May 2016

Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome.

Authors:

Julia Dorn Alexandra Yassouridis Axel Walch Eleftherios P Diamandis Manfred Schmitt Marion Kiechle Ping Wang Enken Drecoll Barbara Schmalfeldt Daniela Loessner Matthias Kotzsch Viktor Magdolen

Am J Cancer Res 2016 15;6(1):61-70. Epub 2015 Dec 15.

Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München Munich, Germany.

View Article

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759397	PMC

April 2016

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

Authors:

Günter Emons Christian Kurzeder Barbara Schmalfeldt Petra Neuser Nikolaus de Gregorio Jacobus Pfisterer Tjoung-Won Park-Simon Sven Mahner Willibald Schröder Hans-Joachim Lück Martin Leonhard Heubner Lars Hanker Falk Thiel Felix Hilpert

Gynecol Oncol 2016 Mar 28;140(3):450-6. Epub 2015 Dec 28.

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Gynäkologie und Geburtshilfe, Arnold-Heller-Str. 3, Haus 24, 24105 Kiel, Germany,. Electronic address:

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2015.12.025	DOI Listing

March 2016

The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.

Authors:

Hagen Sjard Bachmann Werner Meier Andreas du Bois Rainer Kimmig Jan Dominik Kuhlmann Winfried Siffert Jalid Sehouli Kerstin Wollschlaeger Jens Huober Peter Hillemanns Alexander Burges Barbara Schmalfeldt Behnaz Aminossadati Pauline Wimberger

Br J Clin Pharmacol 2015 Nov 22;80(5):1139-48. Epub 2015 Jul 22.

Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/bcp.12688	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631186	PMC

November 2015

The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study.

Authors:

Christina Fotopoulou Jalid Sehouli Nina Ewald-Riegler Nikolaus de Gregorio Alexander Reuss Rolf Richter Sven Mahner Friedrich Kommoss Barbara Schmalfeldt Tanja Fehm Lars Hanker Pauline Wimberger Ulrich Canzler Jacobus Pfisterer Stefan Kommoss Steffen Hauptmann Andreas du Bois

Int J Gynecol Cancer 2015 Sep;25(7):1248-52

*Department of Gynecology Charité, Campus Virchow Klinikum, Berlin, Germany; †Imperial College London, London, United Kingdom; ‡Gynäkologie & Gynäkologische Onkologie, Dr. Horst Schmidt Klinik, Wiesbaden; §Frauenklinik Universitätsklinikum Ulm, Ulm; ∥Coordinating Center for Clinical Trials, University Marburg, Marburg; ¶Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg; #Referenzzentrum für Gynäkopathologie, Institut für Pathologie, Mannheim; **Frauen- und Poliklinik, Klinikum der Technischen Universität, Muenchen; ††Frauenklinik Universitätsklinikum Tuebingen, Tuebingen; ‡‡Frauenheilkunde und Geburtshilfe, Klinikum der J.W. Goethe-Universität, Frankfurt; §§Klinik für Frauenheilkunde und Geburtshilfe der Universität Duisburg-Essen, Essen; ∥∥Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Technische Universität Dresden, Dresden; ¶¶Zentrum für Gynäkologische Onkologie, Kiel; ##Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; ***Universitätsklinik und Poliklinik für Gynäkologie, Universitätsklinikum, Halle; and †††Gynäkologie & Gynäkologische Onkologie, Kliniken Essen-Mitte, Essen, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/IGC.0000000000000476	DOI Listing

September 2015

Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.

Authors:

Martin Pölcher Steffen Hauptmann Christina Fotopoulou Barbara Schmalfeldt Ivo Meinhold-Heerlein Alexander Mustea Ingo Runnebaum Jalid Sehouli

Arch Gynecol Obstet 2015 Jul 26;292(1):231-4. Epub 2015 Apr 26.

Rotkreuzklinikum München, Frauenklinik, Taxisstraße 3, 80637, München, Germany,

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00404-015-3697-y	DOI Listing

July 2015

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.

Authors:

Julia Dorn Holger Bronger Ronald Kates Julia Slotta-Huspenina Barbara Schmalfeldt Marion Kiechle Eleftherios P Diamandis Antoninus Soosaipillai Manfred Schmitt Nadia Harbeck

Oncol Lett 2015 Jan 24;9(1):418-424. Epub 2014 Oct 24.

Department of Obstetrics and Gynecology, Breast Center, Klinikum Grosshadern, University of Munich, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3892/ol.2014.2630	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246645	PMC

January 2015

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

Authors:

Amit M Oza David Cibula Ana Oaknin Benzaquen Christopher Poole Ron H J Mathijssen Gabe S Sonke Nicoletta Colombo Jiří Špaček Peter Vuylsteke Holger Hirte Sven Mahner Marie Plante Barbara Schmalfeldt Helen Mackay Jacqui Rowbottom Elizabeth S Lowe Brian Dougherty J Carl Barrett Michael Friedlander

Lancet Oncol 2015 Jan 4;16(1):87-97. Epub 2014 Dec 4.

Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/S1470-2045(14)71135-0	DOI Listing

January 2015

Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer.

Authors:

Gabriele Mittermeyer Katharina Malinowsky Christian Beese Heinz Höfler Barbara Schmalfeldt Karl-Friedrich Becker Stefanie Avril

PLoS One 2013 28;8(10):e77825. Epub 2013 Oct 28.

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF	Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0077825	PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810127	PMC

September 2014

High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.

Authors:

Juliane Volkmann Ute Reuning Martina Rudelius Norman Häfner Tibor Schuster Aaron Becker V Ros Joerg Weimer Felix Hilpert Marion Kiechle Matthias Dürst Norbert Arnold Barbara Schmalfeldt Alfons Meindl Juliane Ramser

Int J Cancer 2013 Jun 27;132(12):2820-32. Epub 2012 Dec 27.

Clinic of Gynecology and Obstetrics, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/ijc.27975	DOI Listing

June 2013

Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.

Eur J Cancer 2013 May 13;49(8):1905-14. Epub 2013 Mar 13.

Gynäkologie & Gynäkologische Onkologie, Kliniken Essen-Mitte, Essen, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2013.01.035	DOI Listing

May 2013

Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.

J Clin Oncol 2013 Apr 11;31(12):1554-61. Epub 2013 Mar 11.

Kliniken Essen-Mitte, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2012.46.4057	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795662	PMC

April 2013

Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.

Authors:

Stefanie Avril Ellen Hahn Katja Specht Steffen Hauptmann Cornelia Höss Marion Kiechle Heinz Höfler Barbara Schmalfeldt

Gynecol Oncol 2012 Dec 18;127(3):516-24. Epub 2012 Sep 18.

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2012.08.027	DOI Listing

December 2012

Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients.

Authors:

Silke Steinbach Walter Hundt Barbara Schmalfeldt Christina Böhner Sabina Berktold Petra Wolf Nadia Harbeck

Arch Gynecol Obstet 2012 Aug 6;286(2):473-80. Epub 2012 Apr 6.

Department of Otorhinolaryngology, Philipps University, Baldingerstrasse, 35033 Marburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00404-012-2307-5	DOI Listing

August 2012

Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.

Authors:

Werner Meier Andreas du Bois Jörn Rau Martina Gropp-Meier Klaus Baumann Jens Huober Kerstin Wollschlaeger Rolf Kreienberg Ulrich Canzler Barbara Schmalfeldt Pauline Wimberger Barbara Richter Willibald Schröder Antje Belau Anne Stähle Alexander Burges Jalid Sehouli

Gynecol Oncol 2012 Aug 4;126(2):236-40. Epub 2012 May 4.

Department of Gynecology and Obstetrics, Evangelisches Krankenhaus Duesseldorf, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2012.04.050	DOI Listing

August 2012

Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.

Authors:

Lina Seiz Julia Dorn Matthias Kotzsch Axel Walch Nicolai I Grebenchtchikov Apostolos Gkazepis Barbara Schmalfeldt Marion Kiechle Jane Bayani Eleftherios P Diamandis Rupert Langer Fred C G J Sweep Manfred Schmitt Viktor Magdolen

Biol Chem 2012 Apr;393(5):391-401

Klinische Forschergruppe der Frauenklinik der Technischen Universität München, Klinikum rechts der Isar, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1515/hsz-2011-0264	DOI Listing

April 2012

Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3).

Authors:

Michael Jäger Alexandra Schoberth Peter Ruf Juergen Hess Michael Hennig Barbara Schmalfeldt Pauline Wimberger Michael Ströhlein Bettina Theissen Markus M Heiss Horst Lindhofer

Cancer Res 2012 Jan 1;72(1):24-32. Epub 2011 Nov 1.

TRION Research GmbH, Martinsried, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2235	DOI Listing

January 2012

mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.

Authors:

Matthias Kotzsch Julia Dorn Kristina Doetzer Barbara Schmalfeldt Janna Krol Gustavo Baretton Marion Kiechle Manfred Schmitt Viktor Magdolen

Biol Chem 2011 Nov;392(11):1047-51

Institut für Pathologie, Technische Universität Dresden, D-01307 Dresden, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1515/BC.2011.166	DOI Listing

November 2011

Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer.

Authors:

Chee K Lee Michael Friedlander Chris Brown Val J Gebski Alexander Georgoulopoulos Ignace Vergote Sandro Pignata Nicoletta Donadello Barbara Schmalfeldt Rémy Delva Mansoor Raza Mirza Philippe Sauthier Eric Pujade-Lauraine Sarah J Lord R John Simes

J Natl Cancer Inst 2011 Sep 11;103(17):1338-42. Epub 2011 Aug 11.

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, Sydney, NSW 1450, Australia.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1093/jnci/djr282	DOI Listing

September 2011

Ovarian cancer: diagnosis and treatment.

Authors:

Alexander Burges Barbara Schmalfeldt

Dtsch Arztebl Int 2011 Sep 23;108(38):635-41. Epub 2011 Sep 23.

Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe-Großhadern.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.3238/arztebl.2011.0635	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198226	PMC

September 2011

Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO.

Int J Gynecol Cancer 2011 Feb;21(2):289-95

Department of Gynecology & Gynecologic Oncology, Dr. Horst Schmidt Klinik, Wiesbaden, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/IGC.0b013e31820aaafd	DOI Listing

February 2011

Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients.

Authors:

Susanne Hipp Daniela Berg Bilge Ergin Tibor Schuster Alexander Hapfelmeier Axel Walch Stefanie Avril Barbara Schmalfeldt Heinz Höfler Karl-Friedrich Becker

Virchows Arch 2010 Dec 19;457(6):705-13. Epub 2010 Oct 19.

Institut für Pathologie, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00428-010-0986-5	DOI Listing

December 2010

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.

Int J Cancer 2010 Nov;127(9):2209-21

Department of Surgery, Cologne-Merheim Medical Center, University of Witten-Herdecke, Cologne, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1002/ijc.25423	DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958458	PMC

November 2010

Gustatory and olfactory function in breast cancer patients.

Authors:

Silke Steinbach Walter Hundt Thomas Zahnert Sabina Berktold Christina Böhner Nina Gottschalk Moritz Hamann Monika Kriner Petra Heinrich Barbara Schmalfeldt Nadia Harbeck

Support Care Cancer 2010 Jun 3;18(6):707-13. Epub 2009 Jun 3.

Department of Otorhinolaryngology, Technical University, Dresden, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00520-009-0672-9	DOI Listing

June 2010

Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).

Authors:

Pauline Wimberger Michael Wehling Nils Lehmann Rainer Kimmig Barbara Schmalfeldt Alexander Burges Philipp Harter Jacobus Pfisterer Andreas du Bois

Ann Surg Oncol 2010 Jun 18;17(6):1642-8. Epub 2010 Feb 18.

Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF	Source
http://link.springer.com/10.1245/s10434-010-0964-9	Publisher Site
http://dx.doi.org/10.1245/s10434-010-0964-9	DOI Listing

June 2010

Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications.

Authors:

Stefan Paepke Rainer Schmid Stefanie Fleckner Daniela Paepke Markus Niemeyer Barbara Schmalfeldt Volker R Jacobs Marion Kiechle

Ann Surg 2009 Aug;250(2):288-92

Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1097/SLA.0b013e3181b0c7d8	DOI Listing

August 2009

Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.

Authors:

Gabriele Hölscher Christoph Anthuber Gunther Bastert Alexander Burges Doris Mayr Ernst Oberlechner Gabriele Schubert-Fritschle Sonja Sinz Harald Sommer Barbara Schmalfeldt Jutta Engel

Acta Obstet Gynecol Scand 2009 ;88(4):440-8

Department of Medical Informatics, Biometry and Epidemiology, Munich Cancer Registry of the Munich Cancer Center, Ludwig-Maximilian-University, Germany.

View Article

Download full-text PDF	Source
http://doi.wiley.com/10.1080/00016340902741208	Publisher Site
http://dx.doi.org/10.1080/00016340902741208	DOI Listing

April 2009

Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies.

Authors:

Silke Steinbach Thomas Hummel Christina Böhner Sabina Berktold Walter Hundt Monika Kriner Petra Heinrich Harald Sommer Claus Hanusch Anita Prechtl Burghart Schmidt Ingo Bauerfeind Katharina Seck Volker R Jacobs Barbara Schmalfeldt Nadia Harbeck

J Clin Oncol 2009 Apr 16;27(11):1899-905. Epub 2009 Mar 16.

Smell and Taste Clinic, Department of Otorhinolaryngology, Technical University, Dresden, Dresden, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2008.19.2690	DOI Listing

April 2009

Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany.

Authors:

Jacobus Pfisterer Andreas Du Bois Eva-Katrin Bentz Friedrich Kommoss Philipp Harter Jens Huober Barbara Schmalfeldt Nicole Burchardi Norbert Arnold Felix Hilpert

Int J Gynecol Cancer 2009 Jan;19(1):109-15

Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1111/IGC.0b013e3181991a7c	DOI Listing

January 2009

Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.

Authors:

Guelten Oskay-Oezcelik Dominique Koensgen Hans-Joachim Hindenburg Peter Klare Barbara Schmalfeldt Werner Lichtenegger Radoslav Chekerov Salah-Eddin Al-Batran Ulf Neumann Jalid Sehouli

Anticancer Res 2008 Mar-Apr;28(2B):1329-34

Department of Gynecology and Obstetrics, Charité University Hospital Berlin, Berlin, Germany.

View Article

Download full-text PDF	Source

June 2008

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

Authors:

Christina Fotopoulou Andreas duBois Alexandros N Karavas Ralf Trappe Behnaz Aminossadati Barbara Schmalfeldt Jacobus Pfisterer Jalid Sehouli

J Clin Oncol 2008 Jun;26(16):2683-9

Department of Gynecology and Obstetrics, Charité University Hospital, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.2008.16.1109	DOI Listing

June 2008

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

Authors:

Alexander Burges Pauline Wimberger Carolin Kümper Vera Gorbounova Harald Sommer Barbara Schmalfeldt Jacobus Pfisterer Michail Lichinitser Anatoliy Makhson Vladimir Moiseyenko Angelika Lahr Elisabeth Schulze Michael Jäger Michael A Ströhlein Markus Maria Heiss Thomas Gottwald Horst Lindhofer Rainer Kimmig

Clin Cancer Res 2007 Jul;13(13):3899-905

Department of Obstetrics, Ludwig-Maximilans University, Munich Grosshadern, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2769	DOI Listing

July 2007

Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer.

Authors:

Stefanie Sassen Barbara Schmalfeldt Norbert Avril Walther Kuhn Raymonde Busch Heinz Höfler Falko Fend Jörg Nährig

Hum Pathol 2007 Jun 30;38(6):926-34. Epub 2007 Mar 30.

Department of Pathology, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.humpath.2006.12.008	DOI Listing

June 2007

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).

Authors:

Uwe Wagner Andreas du Bois Jacobus Pfisterer Jens Huober Sybille Loibl Hans-Joachim Lück Jalid Sehouli Martina Gropp Anne Stähle Barbara Schmalfeldt Werner Meier Christian Jackisch

Gynecol Oncol 2007 Apr 11;105(1):132-7. Epub 2006 Dec 11.

Department of Gynecology, Gynecologic Endocrinology and Oncology, Philipps-University Marburg, Baldingerstrasse, D-35043 Marburg, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ygyno.2006.10.053	DOI Listing

April 2007

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.

Authors:

Julia Dorn Manfred Schmitt Ronald Kates Barbara Schmalfeldt Marion Kiechle Andreas Scorilas Eleftherios P Diamandis Nadia Harbeck

Clin Cancer Res 2007 Mar;13(6):1742-8

Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2482	DOI Listing

March 2007

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.

Ann Surg Oncol 2006 Dec;13(12):1702-10

Department of Gynecology & Gynecologic Oncology, HSK, Dr. Horst Schmidt Klinik Wiesbaden, Ludwig-Erhard-Strasse 100, Wiesbaden, D-65199, Germany.

View Article

Download full-text PDF	Source
http://dx.doi.org/10.1245/s10434-006-9058-0	DOI Listing

December 2006

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Authors:

Julia Dorn Nadia Harbeck Ronald Kates Viktor Magdolen Linda Grass Antoninus Soosaipillai Barbara Schmalfeldt Eleftherios P Diamandis Manfred Schmitt

Biol Chem 2006 Aug;387(8):1121-8

Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.

View Article